Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Understanding what to look for in a retirement plan review is essential for achieving your financial goals. Stay informed and proactive.
22,069 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
When SpaceX first hit the public markets, traders expected spectacle but not necessarily sustainability. A surprising...
AI momentum is reshaping the market today. We break down what’s moving stocks, why tech names are rallying, and how i...
As 2025 unfolds, virtra (vtsi) earnings will hinge on how the company scales its training systems, monetizes software...
Lionsgate faces a pivotal year as it balances streaming momentum with theatrical cycles and debt. This guide breaks d...
In June’s shifting markets, automation stocks like UiPath are under the microscope. This article explains why ARR gro...
Casual dining is turning a corner. Chili's posted an eye-catching 8.6% same-store sales gain, signaling a broader shi...
AI investing is about balance: a pure data-analytics play versus an autos-and-hardware powerhouse. This article compa...
Salesforce’s AI roadmap has captivated many, but the stock has faced a steep pullback. This article weighs the bulls’...
Icon stock crushed Wednesday as the CRO leader posted a stronger quarter than expected. We break down what drove the ...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...